Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1974-7-5
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0008-6215
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
135-51
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:4826514-Animals,
pubmed-meshheading:4826514-Antineoplastic Agents,
pubmed-meshheading:4826514-Arabinose,
pubmed-meshheading:4826514-Leukemia L1210,
pubmed-meshheading:4826514-Methods,
pubmed-meshheading:4826514-Mice,
pubmed-meshheading:4826514-Pyrazoles,
pubmed-meshheading:4826514-Pyrimidine Nucleosides
|
pubmed:year |
1974
|
pubmed:articleTitle |
Synthetic C-nucleosides: 3-(alpha- and beta-D-arabinofuranosyl)pyrazolo(4,3-d)pyrimidine-5,7-diones.
|
pubmed:publicationType |
Journal Article
|